Literature DB >> 25295512

[Hospital mortality associated with upper gastrointestinal hemorrhage due to ruptured esophageal varices at the Lomé Campus Hospital in Togo].

O Bouglouga1, A Bagny1, L Lawson-Ananissoh1, M Djibril2.   

Abstract

AIM: To study hospital mortality associated with upper gastrointestinal hemorrhages due to variceal bleeding in the department of hepatology and gastroenterology at the Lome Campus University Hospital. PATIENTS AND
METHOD: This retrospective cross-sectional and analytic study examined the 55 patients admitted for variceal bleeding on upper endoscopies during the 3-year period from January 1, 2008, through December 31, 2010.
RESULTS: These patients accounted for 4.1% of all hospitalizations during the study period in the department. Their average age was 35 years, and their sex-ratio 4. A history of chronic liver disease was found in 65.5%. Liver cirrhosis was the principal cause of the esophageal varices, complicated by hepatocellular carcinoma in 30.9% of them. The mortality rate was 25.5% and was not related to the cause of portal hypertension. All the patients with a recurrence of bleeding died. Mortality was associated with jaundice. Blood transfusion did not significantly improve the prognosis.
CONCLUSION: the mortality rate among patients with upper gastrointestinal hemorrhage linked to variceal bleeding is high in our unit. The prevention of hepatitis virus B is important because it is the main cause of chronic liver disease causing portal hypertension in our department.

Entities:  

Keywords:  Togo; gastrointestinal hemorrhage; mortality; portal hypertension; variceal bleeding

Mesh:

Year:  2014        PMID: 25295512     DOI: 10.1684/mst.2014.0372

Source DB:  PubMed          Journal:  Med Sante Trop        ISSN: 2261-3684


  1 in total

1.  Clinical mortality risk factors of variceal upper gastrointestinal bleeding in a Malagasy surgical intensive care unit.

Authors:  Aurélia Rakotondrainibe; Nadia M P Rahanitriniaina; Harifetra M R Randriamizao; Jasper G Raelison; Rado M Ramanampamonjy; Andriambelo T Rajaonera; François Sztark
Journal:  Afr J Emerg Med       Date:  2020-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.